Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in rats

31 May 1982

journal article
research article
Published by Portland Press Ltd. in Bioscience Reports

Vol. 2 (6) , 391-395
https://doi.org/10.1007/bf01119301

Abstract

The actions of oxyntomodulin and glucagon on pentagastrin-stimulated gastric secretion from the perfused rat stomach were compared; both hormones inhibit secretion in a dose-dependent manner.

This publication has 13 references indexed in Scilit:

Isolation and chemical characterization of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum
Regulatory Peptides, 1983
Glucagon-related peptides in human bowel: Quantitative evaluation by HPLC-radioreceptorassay. Evidence for the presence of glucagon-371 (oxyntomodulin2/bioactive enteroglucagon) and glucagon-29 (pancreatic glucagon)
Regulatory Peptides, 1983
The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glands
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1982
‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action
Bioscience Reports, 1981
Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities
Peptides, 1981
Quantitative ultrastructural analysis of the human parietal cell during acid inhibition and increase of gastric potential difference by glucagon.
Gut, 1980
Utilization of the perfused stomach in anaesthetized rats to study the inhibitory effect of somatostatin in gastric acid secretion
Inflammation Research, 1979
Fat-Induced Jejunal Inhibition of Gastric Acid Secretion and Release of Pancreatic Glucagon, Enteroglucagon, Gastric Inhibitory Polypeptide, and Vasoactive Intestinal Polypeptide in Man
Scandinavian Journal of Gastroenterology, 1979
Studies on gastrin: Part I A method of biological assay of gastrin
Gut, 1964